D. E. Shaw & Co., Inc. Wave Life Sciences Ltd. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 418,461 shares of WVE stock, worth $4.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

418,461

Holding current value

$4.98 Million

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.12 - $9.01 $1.59 Million - $2.79 Million	309,894 Added 285.44%	418,461 $3.43 Million
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $773,179 - $1.14 Million	-176,525 Reduced 61.92%	108,567 $541,000
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $1.01 Million - $1.95 Million	285,092 New	285,092 $1.76 Million
Q3 2022 Nov 14, 2022	SELL	$2.37 - $4.28 $1.5 Million - $2.71 Million	-633,290 Reduced 67.34%	307,175 $1.11 Million
Q2 2022 Aug 15, 2022	SELL	$1.23 - $3.25 $185,527 - $490,213	-150,835 Reduced 13.82%	940,465 $3.06 Million
Q1 2022 May 16, 2022	SELL	$2.0 - $3.28 $37,978 - $62,283	-18,989 Reduced 1.71%	1,091,300 $2.18 Million
Q4 2021 Feb 14, 2022	BUY	$3.14 - $5.15 $27,126 - $44,490	8,639 Added 0.78%	1,110,289 $3.49 Million
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.12 $752,619 - $1.1 Million	-153,910 Reduced 12.26%	1,101,650 $5.4 Million
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $37,001 - $48,921	-6,549 Reduced 0.52%	1,255,560 $8.36 Million
Q1 2021 May 17, 2021	SELL	$5.61 - $12.01 $1.33 Million - $2.85 Million	-237,150 Reduced 15.82%	1,262,109 $7.08 Million
Q4 2020 Feb 16, 2021	BUY	$6.99 - $9.26 $5.54 Million - $7.34 Million	792,844 Added 112.23%	1,499,259 $11.8 Million
Q3 2020 Nov 16, 2020	BUY	$8.49 - $19.54 $1.23 Million - $2.82 Million	144,454 Added 25.71%	706,415 $6 Million
Q2 2020 Aug 14, 2020	BUY	$7.44 - $11.29 $3.94 Million - $5.98 Million	529,849 Added 1650.0%	561,961 $5.85 Million
Q1 2020 May 15, 2020	BUY	$6.94 - $14.22 $66,374 - $136,000	9,564 Added 42.42%	32,112 $301,000
Q4 2019 Feb 14, 2020	BUY	$7.99 - $37.6 $30,825 - $145,060	3,858 Added 20.64%	22,548 $181,000
Q3 2019 Nov 14, 2019	SELL	$19.17 - $27.4 $1.29 Million - $1.84 Million	-67,289 Reduced 78.26%	18,690 $384,000
Q2 2019 Aug 14, 2019	SELL	$22.93 - $42.84 $3.59 Million - $6.71 Million	-156,665 Reduced 64.57%	85,979 $2.24 Million
Q1 2019 May 15, 2019	BUY	$32.69 - $47.91 $3.84 Million - $5.62 Million	117,353 Added 93.66%	242,644 $9.43 Million
Q4 2018 Feb 14, 2019	BUY	$37.1 - $50.11 $600,166 - $810,629	16,177 Added 14.83%	125,291 $5.27 Million
Q3 2018 Nov 14, 2018	BUY	$36.35 - $55.2 $1.13 Million - $1.72 Million	31,142 Added 39.94%	109,114 $5.46 Million
Q2 2018 Aug 14, 2018	BUY	$33.85 - $50.65 $708,142 - $1.06 Million	20,920 Added 36.67%	77,972 $2.98 Million
Q1 2018 May 15, 2018	BUY	$32.45 - $54.7 $1.64 Million - $2.77 Million	50,610 Added 785.63%	57,052 $2.29 Million
Q4 2017 Feb 14, 2018	BUY	$21.8 - $39.35 $140,435 - $253,492	6,442	6,442 $226,000

Others Institutions Holding WVE

# of Institutions

165

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.03B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account